<level>
  <type>section</type>
  <num>48-902.12</num>
  <heading>Schedule V enumerated.</heading>
  <text>The controlled substances listed in this section are included in Schedule V unless and until removed therefrom pursuant to § 48-902.01.</text>
  <level>
    <num>(1)</num>
    <text>Any compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or salts thereof, which also contains 1 or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:</text>
    <level>
      <num>(A)</num>
      <text>Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;</text>
    </level>
    <level>
      <num>(B)</num>
      <text>Not more than 100 milligrams of opium per 100 milliliters or per 100 grams;</text>
    </level>
    <level>
      <num>(C)</num>
      <text>Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams;</text>
    </level>
    <level>
      <num>(D)</num>
      <text>Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams;</text>
    </level>
    <level>
      <num>(E)</num>
      <text>Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit; and</text>
    </level>
    <level>
      <num>(F)</num>
      <text>Not more than 0.5 milligrams of difenopin and not less than 25 micrograms of atropine sulfate per dosage unit;</text>
    </level>
  </level>
  <level>
    <num>(2)</num>
    <text>Repealed;</text>
  </level>
  <level>
    <num>(3)</num>
    <text>Deleted upon adoption of rule in 34 DCMR 4370 on July 10, 1987;</text>
  </level>
  <level>
    <num>(4)</num>
    <text>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs and their salts, as set forth below:</text>
  </level>
  <text>Buprenorphine;</text>
  <level>
    <num>(5)</num>
    <text>Prophylhexedrine; and</text>
  </level>
  <level>
    <num>(6)</num>
    <text>Pyrovalerone.</text>
  </level>
  <level>
    <type>annotations</type>
    <level>
      <heading>History</heading>
      <text>(Aug. 5, 1981, D.C. Law 4-29, § 212, 28 DCR 3081; amended by rule, 39 DCR 1882; June 8, 2001, D.C. Law 13-300, § 2(b), 47 DCR 7037.)</text>
    </level>
    <level>
      <heading>Section References</heading>
      <text>This section is referenced in § 7-3002, § 44-1201, § 48-902.01, § 48-902.02, and § 48-1004.</text>
    </level>
    <level>
      <heading>Prior Codifications</heading>
      <text>1981 Ed., § 33-522.</text>
    </level>
    <level>
      <heading>Effect of Amendments</heading>
      <text>D.C. Law 13-300 repealed par. (2) which had read: "(2) Cannabis;".</text>
    </level>
    <level>
      <heading>Legislative History of Law 4-29</heading>
      <text>For legislative history of D.C. Law 4-29, see Historical and Statutory Notes following § 48-901.02.</text>
    </level>
    <level>
      <heading>Legislative History of Law 13-300</heading>
      <text>For D.C. Law 13-300, see notes following § 48-902.08.</text>
    </level>
  </level>
</level>
